Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Morel

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1997
Crossregulation between T helper cell (Th)1 and Th2: inhibition of Th2 proliferation by IFN-gamma involves interference with IL-1T B Oriss, S A McCarthy, B F Morel, et al.
Annals of the New York Academy of Sciences|December 30, 1991
Proto-oncogene transcription after activation of Th-1 and Th-2 cellsP A Morel, J A Walker, A M Livingstone, et al.
Human Immunology|February 1, 1990
Shared molecular markers of genetic predisposition to seropositive rheumatoid arthritisP A Morel, G T Horn, R C Budd, et al.
Blood|April 18, 1998
Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcgammaRIIC geneD Metes, L K Ernst, W H Chambers, et al.
Transplantation|October 1, 1993
A dual mechanism of immunosuppression by FK-506. Differential suppression of IL-4 and IL-10 levels in T helper 2 cellsS C Wang, P A Morel, Q Wang, et al.
Blood|July 15, 1992
Modulation of myeloid proliferation and differentiation by monoclonal antibodies directed against a protein that interacts with the interleukin-3 receptorD J Tweardy, P A Morel, P L Mott, et al.
Cellular Immunology|May 25, 1997
Modeling the proliferative response of T cells to IL-2 and IL-4M A Burke, B F Morel, T B Oriss, et al.
Diabetes|December 2, 1999
Immunotherapy of NOD mice with bone marrow-derived dendritic cellsM Feili-Hariri, X Dong, S M Alber, et al.
Bulletin of Mathematical Biology|May 1, 1996
Making sense of the combined effect of interleukin-2 and interleukin-4 on lymphocytes using a mathematical modelB F Morel, M A Burke, J Kalagnanam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequencesJ R Grandis, D M Falkner, M F Melhem, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1997
Crossregulation between T helper cell (Th)1 and Th2: inhibition of Th2 proliferation by IFN-gamma involves interference with IL-1T B Oriss, S A McCarthy, B F Morel, et al.
Annals of the New York Academy of Sciences|December 30, 1991
Proto-oncogene transcription after activation of Th-1 and Th-2 cellsP A Morel, J A Walker, A M Livingstone, et al.
Human Immunology|February 1, 1990
Shared molecular markers of genetic predisposition to seropositive rheumatoid arthritisP A Morel, G T Horn, R C Budd, et al.
Blood|April 18, 1998
Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcgammaRIIC geneD Metes, L K Ernst, W H Chambers, et al.
Transplantation|October 1, 1993
A dual mechanism of immunosuppression by FK-506. Differential suppression of IL-4 and IL-10 levels in T helper 2 cellsS C Wang, P A Morel, Q Wang, et al.
Blood|July 15, 1992
Modulation of myeloid proliferation and differentiation by monoclonal antibodies directed against a protein that interacts with the interleukin-3 receptorD J Tweardy, P A Morel, P L Mott, et al.
Cellular Immunology|May 25, 1997
Modeling the proliferative response of T cells to IL-2 and IL-4M A Burke, B F Morel, T B Oriss, et al.
Diabetes|December 2, 1999
Immunotherapy of NOD mice with bone marrow-derived dendritic cellsM Feili-Hariri, X Dong, S M Alber, et al.
Bulletin of Mathematical Biology|May 1, 1996
Making sense of the combined effect of interleukin-2 and interleukin-4 on lymphocytes using a mathematical modelB F Morel, M A Burke, J Kalagnanam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequencesJ R Grandis, D M Falkner, M F Melhem, et al.
Pageof 6